1 / 2

Interventional Cardiology Products Market by type - Global Forecast to 2022

<br>The global Interventional Cardiology Products Market is expected to reach USD 20.85 Billion by 2022 from USD 14.52 Billion in 2017, at a CAGR of 7.5%. Market growth is primarily driven by the growing incidence of CVD and technological advancements in interventional cardiology devices.<br>

poonam26
Download Presentation

Interventional Cardiology Products Market by type - Global Forecast to 2022

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Interventional Cardiology Products Market by type - Global Forecast to 2022 The global Interventional Cardiology Products Market is expected to reach USD 20.85 Billion by 2022 from USD 14.52 Billion in 2017, at a CAGR of 7.5%. Market growth is primarily driven by the growing incidence of CVD and technological advancements in interventional cardiology devices. The global Interventional Cardiology Products Market is segmented based on type and region. By type, the global market is segmented into angioplasty balloons, angioplasty stents, catheters, plaque modification devices, hemodynamic flow alteration devices, and other devices. The angioplasty stents segment is estimated to account for the largest market of the global market in 2017. Factors driving the growth of this segment include the widespread use of stents. Request for Sample @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=548 The plaque modification devices market is further classified into thrombectomy devices and atherectomy devices. The thrombectomy devices segment is estimated to account for the largest share of the global plaque modification devices market. The large share of this segment can be attributed to the increasing demand for plaque removal procedures and rising incidences of plaque deposition. The other Interventional Cardiology Products Market is segmented into guidewires, vascular closure devices, introducer sheaths, and balloon inflation devices. The guidewires segment is estimated to account for the largest share of the global other market. Growth in the number of interventional procedures and increasing use of guidewires in stenting procedures are the major factors driving the growth of this segment. The global Interventional Cardiology Products Market is dominated by North America, followed by Europe. North America will continue to dominate the global market in the forecast period. However, Asia Pacific is expected to witness the highest CAGR, with the growth in this market

  2. centered on Japan, China, and India. Factors such as the rising focus of major players in emerging Asia Pacific countries and government support are driving the growth of the Interventional Cardiology Products Market in this region. Major industry players launched innovative products to maintain and improve their position in the interventional cardiology devices market. Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), Terumo (Japan), Cordis (US), B. Braun (Germany), C.R. Bard (US), Biosensors (Singapore), and BIOTRONIK (Germany) have been identified as key players in this market. To Know More @ https://www.marketsandmarkets.com/Market-Reports/minimally-invasive- interventional-cardiology-devices-market-548.html

More Related